ABIVAX (EPA:ABVX) | WebDisclosure

Basculer en Français

11053	Companies
242357	Keywords
170654	Articles
130448	Press releases

Home
Companies
ABIVAX

PRESS RELEASE

published on 07/22/2025 at 22:06, 1 year 1 month ago

Abivax annonce des résultats positifs de phase 3 pour les deux essais d'induction ABTECT de 8 semaines, évaluant obefazimod dans le traitement de la rectocolite hémorragique
Abivax annonce des résultats positifs de phase 3 pour les essais d'induction ABTECT de 8 semaines, évaluant obefazimod dans le traitement de la rectocolite hémorragique. Résultats de top-line prometteurs

Abivax Obefazimod Rectocolite Hémorragique Phase 3 Top-line
PRESS RELEASE

published on 07/22/2025 at 22:05, 1 year 1 month ago

Abivax Announces Positive Phase 3 Results from Both ABTECT 8-Week Induction Trials Investigating Obefazimod, its First-in-Class Oral miR-124 Enhancer, in Moderate to Severely Active Ulcerative Colitis
Abivax announces positive Phase 3 results for obefazimod in ulcerative colitis trials, meeting key endpoints and demonstrating favorable tolerability. Conference call scheduled for more insights

Abivax Obefazimod Ulcerative Colitis Clinical Trials Phase 3 Results
BRIEF

published on 07/17/2025 at 18:05, 1 year 2 months ago

ABIVAX : Détails sur le capital social et les droits de vote

Nombre D'actions Droits De Vote Capital Social Abivax Investisseurs
BRIEF

published on 07/17/2025 at 18:05, 1 year 2 months ago

ABIVAX: Details on share capital and voting rights

Share Capital Voting Rights Investors Abivax Number Of Shares
PRESS RELEASE

published on 07/17/2025 at 18:00, 1 year 2 months ago

ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote
ABIVAX communique le nombre d'actions composant son capital social et le nombre total de droits de vote conformément aux dispositions réglementaires

Droits De Vote Capital Social Abivax Information Réglementaire Société Biotechnologie
BRIEF

published on 06/19/2025 at 18:05, 1 year 3 months ago

ABIVAX Déclare la Composition de son Capital Social et Droits de Vote

Euronext Paris Droits De Vote Capital Social Abivax Réglementation AMF
BRIEF

published on 06/19/2025 at 18:05, 1 year 3 months ago

ABIVAX Declares the Composition of its Share Capital and Voting Rights

Euronext Paris Share Capital Voting Rights Abivax AMF Regulations
PRESS RELEASE

published on 06/19/2025 at 18:00, 1 year 3 months ago

ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote au 31.05.25.
ABIVAX informe sur le nombre d'actions et de droits de vote au 31.05.25. Détails réglementaires selon le code de commerce et l'AMF

Communication Financière Droits De Vote Capital Social Actions Abivax
BRIEF

published on 06/11/2025 at 22:05, 1 year 3 months ago

Abivax Reports Outcomes of Annual General Meeting

Financial Results Biotechnology Abivax Annual Meeting Board Appointments
BRIEF

published on 06/11/2025 at 22:05, 1 year 3 months ago

Abivax publie les résultats de son assemblée générale annuelle

Résultats Financiers Biotechnologie Abivax Nominations Au Conseil D'administration Assemblée Annuelle

Accesswire

Published on 09/22/2026 at 17:00, 3 hours 16 minutes ago

Leggett Dynamics Expands Asia Pacific Headquarters
Published on 09/22/2026 at 16:30, 3 hours 46 minutes ago

Formation Metals Intersects 0.98 g/t Au over 95.6 Metres Starting 7 Metres Below Surface, Including 3.14 g/t Au over the First 10 Metres, Extending the A-Zone Up to 50 Metres North at N2
Published on 09/22/2026 at 15:25, 4 hours 51 minutes ago

Aztec Minerals Announces Closing of Upsized C$6.4 Million Bought Deal Private Placement Including Concurrent Exercise of Underwriter's Option
Published on 09/22/2026 at 15:20, 4 hours 56 minutes ago

MicroVision Introduces Advanced Photonics Technology for Next-Generation AI Data Center Scale-Up Architecture
Published on 09/22/2026 at 15:05, 5 hours 11 minutes ago

Jaguar Health Receives Fee Waivers from FDA

View all ACCESSWIRE

EQS Group

Published on 09/22/2026 at 19:40, 35 minutes ago

EQS-Adhoc: Pyrum Innovations AG: Revision of the Forecast for the Financial Year 2026
Published on 09/22/2026 at 19:00, 1 hour 16 minutes ago

LLB focuses on its "elevate" strategy for growth, excellence and resilience
Published on 09/22/2026 at 18:45, 1 hour 30 minutes ago

MGI Digital Technology: Modification des ressources allouées au contrat de liquidité.
Published on 09/22/2026 at 18:30, 1 hour 46 minutes ago

Avolta partners with Hawaii’s Department of Transportation to expand airport dining at three airports
Published on 09/22/2026 at 18:30, 1 hour 46 minutes ago

Voyageurs du Monde: Communiqué sur le dépôt de projet de note en réponse (suite au dépôt de projet de note en réponse de Voyageurs du Monde à l'Autorité des Marchés Financiers)

Les Echos

Published on 09/22/2026 at 18:10, 2 hours 6 minutes ago

Financial statements - 30 june 2026
Published on 09/22/2026 at 18:00, 2 hours 16 minutes ago

Consolidated results for the first half of 2026 EBITDA : 60,5 M€
Published on 09/22/2026 at 18:00, 2 hours 16 minutes ago

Résultats consolidés du premier semestre 2026 EBITDA : 60,5 M€
Published on 09/22/2026 at 17:45, 2 hours 31 minutes ago

Imerys-09-2026-information-share-capital-and-voting-rights-as-of-31-August-2026
Published on 09/22/2026 at 17:45, 2 hours 31 minutes ago

Imerys-09-2026-communique-capital-droits-de-vote-au-31-août-2026

View all LES ECHOS COMFI WIRE